Well as a previous holder you should know this was always about Europe once ResAppDx got CE Mark, MSF were only doing field studies and didn't continue (hence why ResAppDx is now being evaluated in clinic in Africa after receiving regulatory approval), the project with Lockheed Martin was completed, we all know why the FDA decline the submission after taking
10 months to review the submission.......
RAP Price at posting:
6.0¢ Sentiment: Buy Disclosure: Held